Evidence map›Paper›PMID 42743208›Full record

ArticlePloS one2026

Characterization of mesenchymal stromal cell-mediated mitochondrial transfer to healthy and diseased intervertebral disc cells.

Ashley Cardenas, Noah Willett, Anthony Robayo, Jessica Berger, Blake Boadi, Chibuikem A Ikwuegbuenyi, Ibrahim Hussain, Roger Härtl, Lawrence J Bonassar

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ashley CardenasMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.ORCID https://orcid.org/0009-0001-9697-260X
Noah WillettDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.
Anthony RobayoDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.
Jessica BergerDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.ORCID https://orcid.org/0009-0001-8667-0173
Blake BoadiDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.
Chibuikem A IkwuegbuenyiDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.ORCID https://orcid.org/0000-0003-3646-7713
Ibrahim HussainDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.
Roger HärtlDepartment of Neurological Surgery, Och Spine at New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York, United States of America.
Lawrence J BonassarMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.ORCID https://orcid.org/0000-0003-1094-6433

Funding

J. NRSA Training CoreTL1TR002386 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Genevieve Giny Fouda Amou ou · 2017 to 2026
$5.8M
Combined Engineering and Orthopaedics Training ProgramT32AR078751 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI MAHER, SUZANNE A., VAN DER MEULEN, MARJOLEIN C · 2021 to 2025
$1.7M
Broad wavelength range Zeiss 780 NLO/confocal system for the Cornell Imaging CoreS10OD018516 · OD · CORNELL UNIVERSITY · PI ZIPFEL, WARREN R · 2014 to 2014
$834k
Acquisition of an automated phase and fluorescence microscope for Cornell BRC Imaging FacilityS10OD032251 · OD · CORNELL UNIVERSITY · PI WILLIAMS, REBECCA M · 2022 to 2022
$229k
NCATS NIH HHS TL1 TR002386NIAMS NIH HHS T32 AR078751NIH HHS S10 OD018516NIH HHS S10 OD032251
6 · The paper itself

Abstract

Intradiscal injection of mesenchymal stromal cells has gained widespread interest for the treatment of intervertebral disc degeneration. Mesenchymal stromal cells have been shown to impart a therapeutic benefit on treated tissues through a variety of mechanisms including mitochondrial transfer. Mitochondrial transfer from mesenchymal stromal cells to diseased cells has been demonstrated, in numerous model systems, to increase the survival and function of recipient cells. To date there are few studies that have investigated mitochondrial transfer from mesenchymal stromal cells to intervertebral disc cells. The goal of this study is to characterize mitochondrial transfer from mesenchymal stromal cells to bovine and human intervertebral disc cells using confocal microscopy. Following a 24-hour coculture period, bovine mesenchymal stromal cells were shown to transfer mitochondria to bovine annulus fibrosus cells under both healthy and inflammatory conditions. In addition, human mesenchymal stromal cells were shown to transfer mitochondria to diseased, patient-derived intervertebral disc cells. Mitochondrial transfer quantity was found to increase under inflammatory stress conditions and with patient age, though functional consequences of this transfer remain to be determined. This study is the first to show mesenchymal stromal cells transfer mitochondria to bovine annulus fibrosus cells and patient derived intervertebral disc cells. We provide evidence that mitochondrial transfer is a relevant mechanism by which mesenchymal stromal cells communicate with intervertebral disc cells.

Indexed as

Intervertebral DiscIntervertebral Disc DegenerationMesenchymal Stem CellsMitochondriaAnimalsAnnulus FibrosusCattleCells, CulturedCoculture TechniquesHumans

Identifiers

PMID42743208
PMCPMC13577375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.